• Ipsos
  • Insights Hub
  • Targeting the Affluent: Differential Access to Targeted Therapies in China

Targeting the Affluent: Differential Access to Targeted Therapies in China

Conquering Complexity, at a Price. This paper will illustrate how disparities in income levels continue to drive far-reaching differences in the way poorer and richer Chinese with cancer are being treated for their disease.

The war against cancer is now being fought at a molecular level – harnessing the insights we have gained into the complexity of our enemy. However, this revolution is, quite literally, coming at a price. This new molecular battlefront isn’t just complex; it is incredibly hungry for money.

Different countries around the world have adopted the new tactics and tools at varying speeds and with markedly different levels of success. In particular, there is substantial variability between different countries’ ability to ensure equal access to the most effective – and often the most expensive – drug treatments for all citizens diagnosed with cancer.

Using data from the Ipsos Global Oncology Monitor ©, Pieter De Richter – Head of Real World Evidence in APAC and MENA – looks in-depth at China, exploring the differential access to anti-cancer therapies in this key Asian market.

Download

The author(s)

  • Pieter De Richter
    Pieter De Richter
    Regional Service Line Leader, Healthcare in APAC, Malaysia

More insights about Health

Related news

  • The Human Advantage Conference 2026: Highlights
    Artificial Intelligence (AI) Events replay

    The Human Advantage Conference 2026: Highlights

    Ipsos is proud to support The Human Advantage 2026, a flagship event bringing together some of the world's leading experts and key industry figures to explore how behavioural science, AI, and human intelligence can address the critical challenges facing businesses and society. Here's a look back at two days of live coverage.
  • [WEBINAR] KEYS: Dialling Up the S In Sustainability
    KEYS Events replay

    [REPLAY] KEYS: Dialling Up the S In Sustainability

    In the next episode of our KEYS webinar, we’ll be asking whether now is the time when organisations should be ‘dialling up the S’ in their sustainability initiatives.
  • [Webinar] Real-World Evidence: Empowering the Patient
    Healthcare Webinar

    [Replay] Real-World Evidence: Empowering the Patient

    Patient voices are now central to regulatory, HTA and commercial decisions. But how do we move beyond tick-box engagement to evidence that truly reflects lived experience? Join our expert panel for a 360° perspective on making patient-centricity work in practice.